CLL October 16, 2003 AL amyloidosis May 7, 2009 August 31, 2010 Ischemic heart disease (IHD) chronic B-cell leukemia, and disease Parkinson’s Early-onset PN September 6, 2013 The table above includes reference to acute and subacute PN Important: becoming subject to presumptive SC on November 7, 1996, for historical purposes. The covered disease was revised to early-onset PN by change effective September 6, 2013. For claims on or after September 6, 2013, entitlement to presumptive SC based on PN only exists when the Veteran meets qualifying service requirements specified at M21-1, Part IV, Subpart ii, 2.C.3.e and medical evidence establishes a confirmed diagnosis of early-onset PN. Unless an earlier effective date is determined pursuant to the Note: Nehmer stipulation under , the provisions pertaining to retroactive payment under apply. For more information on the stipulation, see M21-1, Part Reference: Nehmer IV, Subpart ii, 2.C.4. A change to and () effective September 6, 2013, removed requirements that j. Processing Claims Based neuropathy must resolve within two years. on Early-Onset PN Do not deny presumptive SC for early-onset PN solely because the condition persisted for more than two years after initial diagnosis. Important: The regulatory amendment does not change that PN must manifest to a compensable degree of 10 percent or more within one year of the date of last herbicide exposure during active military, naval, or air service. Claims of SC for later-occurring onset of PN can only be evaluated under other bases (for example, direct or secondary). NAS has determined that evidence does not support an association between herbicide exposure and delayed-onset PN, which NAS defined as having its onset more than one year after exposure. For more information on conditions determined to have no Reference: positive association with herbicide exposure, see M21-1, Part IV, Subpart ii, 2.C.3.k. Under the Agent Orange Act of 1991, the Secretary receives from the NAS k. Conditions Determined to periodic reviews and summaries of the scientific evidence concerning the Have No association between exposure to herbicides and diseases suspected to be Positive associated with those exposures.
CLL October 16, 2003 AL amyloidosis May 7, 2009 Ischemic heart disease (IHD) chronic B-cell leukemia, and Parkinson’s disease August 31, 2010 Early-onset PN September 6, 2013 Important: The table above includes reference to acute and subacute PN becoming subject to presumptive SC on November 7, 1996, for historical purposes. The covered disease was revised to early-onset PN by change effective September 6, 2013. For claims on or after September 6, 2013, entitlement to presumptive SC based on PN only exists when the Veteran meets qualifying service requirements specified at M21-1, Part IV, Subpart ii, 2.C.3.e and medical evidence establishes a confirmed diagnosis of early-onset PN. Note: Unless an earlier effective date is determined pursuant to the Nehmer stipulation under , the provisions pertaining to retroactive payment under apply. Reference: For more information on the Nehmer stipulation, see M21-1, Part IV, Subpart ii, 2.C.4. j. Processing Claims Based on Early-Onset PN A change to and () effective September 6, 2013, removed requirements that neuropathy must resolve within two years. Do not deny presumptive SC for early-onset PN solely because the condition persisted for more than two years after initial diagnosis. Important: The regulatory amendment does not change that PN must manifest to a compensable degree of 10 percent or more within one year of the date of last herbicide exposure during active military, naval, or air service. Claims of SC for later-occurring onset of PN can only be evaluated under other bases (for example, direct or secondary). NAS has determined that evidence does not support an association between herbicide exposure and delayed-onset PN, which NAS defined as having its onset more than one year after exposure. Reference: For more information on conditions determined to have no positive association with herbicide exposure, see M21-1, Part IV, Subpart ii, 2.C.3.k. k. Conditions Determined to Have No Positive Under the Agent Orange Act of 1991, the Secretary receives from the NAS periodic reviews and summaries of the scientific evidence concerning the association between exposure to herbicides and diseases suspected to be associated with those exposures.